Your browser doesn't support javascript.
loading
Anticancer immunity induced by a synthetic tumor-targeted CD137 agonist.
Upadhyaya, Punit; Lahdenranta, Johanna; Hurov, Kristen; Battula, Sailaja; Dods, Rachel; Haines, Eric; Kleyman, Marianna; Kristensson, Julia; Kublin, Jessica; Lani, Rachid; Ma, Jun; Mudd, Gemma; Repash, Elizabeth; Van Rietschoten, Katerine; Stephen, Tom; You, Fanglei; Harrison, Helen; Chen, Liuhong; McDonnell, Kevin; Brandish, Philip; Keen, Nicholas.
Afiliación
  • Upadhyaya P; Bicycle Therapeutics, Lexington, Massachusetts, USA.
  • Lahdenranta J; Bicycle Therapeutics, Lexington, Massachusetts, USA.
  • Hurov K; Bicycle Therapeutics, Lexington, Massachusetts, USA.
  • Battula S; Bicycle Therapeutics, Lexington, Massachusetts, USA.
  • Dods R; Bicycle Therapeutics, Babraham Research Campus, Cambridge, UK.
  • Haines E; Bicycle Therapeutics, Lexington, Massachusetts, USA.
  • Kleyman M; Bicycle Therapeutics, Lexington, Massachusetts, USA.
  • Kristensson J; Bicycle Therapeutics, Babraham Research Campus, Cambridge, UK.
  • Kublin J; Bicycle Therapeutics, Lexington, Massachusetts, USA.
  • Lani R; Bicycle Therapeutics, Babraham Research Campus, Cambridge, UK.
  • Ma J; Bicycle Therapeutics, Lexington, Massachusetts, USA.
  • Mudd G; Bicycle Therapeutics, Babraham Research Campus, Cambridge, UK.
  • Repash E; Bicycle Therapeutics, Lexington, Massachusetts, USA.
  • Van Rietschoten K; Bicycle Therapeutics, Babraham Research Campus, Cambridge, UK.
  • Stephen T; Bicycle Therapeutics, Lexington, Massachusetts, USA.
  • You F; Bicycle Therapeutics, Lexington, Massachusetts, USA.
  • Harrison H; Bicycle Therapeutics, Babraham Research Campus, Cambridge, UK.
  • Chen L; Bicycle Therapeutics, Babraham Research Campus, Cambridge, UK.
  • McDonnell K; Bicycle Therapeutics, Lexington, Massachusetts, USA.
  • Brandish P; Bicycle Therapeutics, Lexington, Massachusetts, USA.
  • Keen N; Bicycle Therapeutics, Lexington, Massachusetts, USA nicholas.keen@bicycletx.com.
J Immunother Cancer ; 9(1)2021 01.
Article en En | MEDLINE | ID: mdl-33500260
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos Cíclicos / Receptor EphA2 / Miembro 9 de la Superfamilia de Receptores de Factores de Necrosis Tumoral / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Péptidos Cíclicos / Receptor EphA2 / Miembro 9 de la Superfamilia de Receptores de Factores de Necrosis Tumoral / Neoplasias Tipo de estudio: Prognostic_studies Límite: Animals / Female / Humans Idioma: En Revista: J Immunother Cancer Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos